Vitamin E
Vitamin E (Tocopherols & Tocotrienols)
A fat-soluble antioxidant vitamin that protects cell membranes from oxidative damage and supports skin, cardiovascular, and immune health.
Vitamin E is a family of eight fat-soluble compounds: four tocopherols and four tocotrienols. Alpha-tocopherol is the most biologically active form in humans. It functions primarily as a lipid-soluble antioxidant, protecting cell membranes from oxidative damage. It's important for skin health, immune function, and may support cardiovascular health. Natural mixed tocopherols are preferred over synthetic dl-alpha-tocopherol.
Mechanisms of Action
Lipid Antioxidant
Protects cell membranes from oxidation
Immune Modulation
Enhances immune cell function
Skin Protection
Protects skin from UV and oxidative damage
Recommended Dose
100-400 IU daily (natural d-alpha-tocopherol)
Loading: Not required
Optimal Timing
- With fat-containing meal
- Any time of day
Take with food
Best Form
Natural mixed tocopherols (d-alpha, beta, gamma, delta)
Alternatives: d-alpha-tocopherol (natural), Mixed tocotrienols, dl-alpha-tocopherol (synthetic, less preferred)
Natural 'd' forms are better retained than synthetic 'dl' forms. Mixed tocopherols/tocotrienols provide broader benefits than alpha alone.
Duration
Minimum: 4 weeks
Optimal: 12 weeks
Cycling: Not required
Note: Fat-soluble; absorption significantly improved with dietary fat. Natural form (d-alpha) is preferred over synthetic (dl-alpha).
Personalized Dosage Calculator
Get a dosage recommendation tailored to your body weight, age, goals, and health profile.
Set up your health profile for personalized recommendations
Antioxidant Protection
Reduced oxidative stress markers
Skin Health
Improved skin texture and UV protection
Immune Support
Enhanced immune function, especially in elderly
Bleeding Risk
High doses may increase bleeding risk
Limit to 100-200 IU/day; monitor with doctor
Who Should NOT Take This
- Vitamin K deficiency
- Bleeding disorders
- History of heart failure (high doses ≥400 IU/day)
- Pregnancy - use with caution
- Scheduled Surgery - use with caution
Drug Interactions
May interfere with some treatments; consult oncologist
May enhance anticoagulant effects
May reduce some statin side effects
Possible Side Effects
Tip: Stay under 400 IU/day; stop before surgery
Tip: Take with food
Warnings
- Meta-analyses show high doses (≥400 IU/day) may increase all-cause mortality — stay under 400 IU/day
- High-dose supplementation linked to increased heart failure risk in cardiovascular patients
- Stop 1-2 weeks before surgery due to anticoagulant effects
- Synthetic dl-alpha is less effective than natural d-alpha tocopherol
Top studies from 40+ peer-reviewed papers
Qi S et al. • BMJ open (2024)
“According to the results, vitamin E might be an effective measure to reduce SBP, but more research is needed to validate this finding.”
Key Findings:
- Among the five vitamins, only vitamin E was significantly more effective at reducing SBP (mean difference: -14.14 mm Hg, 95% credible intervals: -27.62 to -0.88) than placebo.
- The dose of vitamins, geographical region and percentage of males (only SBP) might be sources of heterogeneity.
- According to the results, vitamin E might be an effective measure to reduce SBP, but more research is needed to validate this finding.
Vogli S et al. • Nutrients (2023)
“Regarding aspartate aminotransferase (AST), patients in the experimental group experienced a reduction in serum levels, though smaller in absolute values [AST MD = -4.65 IU/L, 95% CI (-7.44, -1.86) in studies conducted in Asian populations] and of lower precision in non-Asian studies [MD = -5.60 IU/L, 95% CI (-11.48, 0.28)].”
Key Findings:
- Three electronic databases (MEDLINE, CENTRAL, and Embase) were reviewed for randomized trials that tested vitamin E supplementation versus placebo or no intervention in patients with NAFLD, published until April 2023.
- A total of 794 patients from 12 randomized trials were included in this meta-analysis.
- Further research warranted to confirm findings
Rumbold A et al. • The Cochrane database of systematic reviews (2015)
“The data do not support routine vitamin E supplementation in combination with other supplements for the prevention of stillbirth, neonatal death, preterm birth, pre-eclampsia, preterm or term PROM or poor fetal growth.”
Key Findings:
- Women supplemented with vitamin E in combination with other supplements compared with placebo were at decreased risk of having a placental abruption (RR 0.64, 95% CI 0.44 to 0.93, seven trials, 14,922 participants, I² = 0%; high quality evidence).
- The data do not support routine vitamin E supplementation in combination with other supplements for the prevention of stillbirth, neonatal death, preterm birth, pre-eclampsia, preterm or term PROM or poor fetal growth.
- Further research is required to elucidate the possible role of vitamin E in the prevention of placental abruption.
- There was no convincing evidence that vitamin E supplementation in combination with other supplements results in other important benefits or harms.
El-Tawil S et al. • The Cochrane database of systematic reviews (2015)
“There is low quality evidence that quinine (200 mg to 500 mg daily) significantly reduces cramp number and cramp days and moderate quality evidence that quinine reduces cramp intensity.”
Key Findings:
- All 23 trials claimed to be randomised, but only a minority described randomisation and allocation concealment adequately.Compared to placebo, quinine significantly reduced cramp number over two weeks by 28%, cramp intensity by 10%, and cramp days by 20%.
- Cramp duration was not significantly affected.A significantly greater number of people suffered minor adverse events on quinine than placebo (risk difference (RD) 3%, 95% confidence interval (CI) 0% to 6%), mainly gastrointestinal symptoms.
- Overdoses of quinine have been reported elsewhere to cause potentially fatal adverse effects, but in the included trials there was no significant difference in major adverse events compared with placebo (RD 0%, 95% CI -1% to 2%).
- One participant suffered from thrombocytopenia (0.12% risk) on quinine.A quinine-vitamin E combination, vitamin E alone, and xylocaine injections into gastrocnemius were not significantly different to quinine across all outcomes, including adverse effects.
Wen H et al. • The Cochrane database of systematic reviews (2024)
“Given the very low certainty evidence, we do not know if long-term treatment (18 months to 24 months) with vitamin E administered alone affects all-cause mortality, serious adverse events, quality of life, or non-serious adverse events in people with NAFLD when compared with placebo or no intervention.”
Key Findings:
- Vitamin E may slightly reduce serum alkaline phosphatase (ALP) levels (MD -5.21, 95% CI -9.88 to -0.54; 5 trials, 416 participants; very low certainty evidence), but the evidence is very uncertain.
- We found no data on liver-related mortality, liver-related morbidity, or proportion of participants without a decrease in liver enzymes.
- Vitamin E likely reduces ALT and AST slightly when compared with placebo, but whether this has any impact on the clinical course in people with NAFLD is unknown.
- The trials on vitamin E plus vitamin C did not report on all-cause mortality, liver-related mortality, serious adverse events, liver-related morbidity, health-related quality of life, or non-serious adverse events.
Study Type Distribution
Goals This Supplement Supports
Related Goals
This information is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any supplement.